Study results
Evaxion’s cancer vaccine shows lasting responses in phase II
Evaxion Biotech has presented promising two-year data from its Phase II study of the personalized cancer vaccine EVX-01 at ESMO 2025. The vaccine,...
Premium
Studieresultat
Clinical advancement for Oncoinvent’s Radspherin
Oncoinvent recently presented the final results from its Phase I study...
Bioteknik
Premium
Studieresultat
Green Light for Higher Doses in Isofol’s Arfolitixorin Study
Isofol has long had high confidence in the potential...
Studieresultat
Hansa Biopharma reaches primary endpoint in phase III study
Hansa Biopharma announces that the drug candidate imlifidase has achieved the...
Premium
Studieresultat
How Sweden will attract more clinical trials
At a time when the life science sector is competing for...
Bioteknik
Premium
Studieresultat
3 out of 4 respond to BioNTech and BMS lung cancer candidate
As BioStock has previously reported, the World Conference...
Bioteknik
Studieresultat
Summit and Akeso plunge into ambiguous data
The candidate who would beat Keytruda on the fingers meets...
Kina
Studieresultat
Fresh from the stomachs of mice
When stomach cells are damaged, they can...
Premium
Studieresultat
Novo Nordisk shows its forefoot in clinical practice
The battle over the obesity market is constantly intensifying and the attacks are intensifying...
Big Pharma
Kina
Obesitas
Studieresultat